These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19098415)

  • 1. [Elderly patient with metastatic gallbladder cancer treated by cisplatin, epirubicin and continuous infusion 5-fluorouracil].
    Yoshida N; Kochi M; Funada T; Mamiya T; Ohkubo R; Kaiga T; Takayama T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2421-3. PubMed ID: 19098415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
    Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced gallbladder carcinoma with liver metastasis showing a favorable response after intra-arterial infusion chemotherapy: report of a case.
    Hara H; Nomura E; Watanabe I; Sako S; Otani M; Tanigawa N
    Surg Today; 1999; 29(10):1102-5. PubMed ID: 10554339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial infusion chemotherapy for advanced gallbladder cancer and liver metastasis].
    Katoh K; Sone M; Nakasato T; Ehara S; Takahashi M; Nitta H; Wakabayashi G
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1691-5. PubMed ID: 18931570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of unresectable advanced gallbladder cancer successfully treated by oral S-1 and hepatic arterial infusion (HAI) of low-dose CDDP therapy].
    Terakura M; Kaneko M; Ikebe T; Yoshioka H; Tanaka H
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):645-7. PubMed ID: 18408436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
    Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of liver metastasis from gallbladder cancer with marked response to arterial infusion chemotherapy].
    Oku T; Yoshizaki N; Waga E; Sumiyoshi T; Ohira N; Nishihori Y; Ohi M; Kondo H; Motohara T; Yoshida Y
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1515-8. PubMed ID: 14584288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
    Ishiguro A; Munakata M; Shitara K; Suzuki K; Takahata T; Itoh J; Sakata Y; Munakata A
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1127-30. PubMed ID: 17637555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with FEP (5-FU, Epirubicin, cisplatin) therapy by continuous venous daily infusion of 5-FU and low-dose CDDP].
    Hoshino K; Kawaguchi H; Unate H; Nitta K; Fukui H; Ikeda M; Tsujitani S
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1197-200. PubMed ID: 8751810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Hepatogastroenterology; 2008; 55(85):1380-4. PubMed ID: 18795694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
    Ocvirk J; Reberšek M; Skof E; Hlebanja Z; Boc M
    Am J Clin Oncol; 2012 Jun; 35(3):237-41. PubMed ID: 21399488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
    Boucher E; Corbinais S; Brissot P; Boudjema K; Raoul JL
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):305-8. PubMed ID: 12357305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil/cisplatin therapy].
    Anami Y; Oguma S; Matsuda Y; Yamaki T; Sazawa Y; Komiya H; Izai J; Ota T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1977-80. PubMed ID: 16282739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
    Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
    Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report-advanced pancreas cancer with liver and lung metastases well controlled over one year by combination therapy with systemic chemotherapy, radiation and hepatic arterial infusion in an outpatient setting].
    Hasuike Y; Tanigawa T; Yamada M; Minami Y; Ezumi K; Kashiwazaki M; Fujimoto T
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2117-9. PubMed ID: 19106542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
    Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of unresectable gallbladder cancer responding to combination therapy with hyperthermia and local chemotherapy].
    Hara Y; Kawasaki T; Yabata E; Gen T; Jibiki M; Kudoh A; Noguchi N; Kataoka T; Teramoto K; Iwai T
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):117-20. PubMed ID: 10660743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.